Trials / Completed
CompletedNCT02537899
Spinal Cord Injury - Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD
A Case Series of Patients With Spinal Cord Injury Treated With Standard Therapies and NeuroAiD
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Moleac Pte Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
SATURN investigates the promising role of NeuroAiD in patients with spinal cord injury and will provide important information on the feasibility of conducting larger controlled trials.
Detailed description
SATURN is a prospective cohort study of patients with moderately-severe to severe spinal cord injury, defined as American Spinal Injury Association Impairment Scale A and B, who are treated with open-label NeuroAiD for 6 months in addition to standard care and followed for 24 months. Anonymized data will be prospectively collected at baseline and months 1, 3, 6, 12, 18, and 24 using a secured online system and will include information on demographics, main diagnostics, neurological and functional state, treatment compliance, concomitant therapies, and side effects, if any.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NeuroAiD |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2023-09-20
- Completion
- 2023-09-20
- First posted
- 2015-09-02
- Last updated
- 2024-03-15
Locations
1 site across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT02537899. Inclusion in this directory is not an endorsement.